Table 1.
Cell Type | Effect of Aberrant IL-1β Signaling |
---|---|
Cancer and stem cells | Promotion of epithelial-to-mesenchymal transition during oncogenesis |
Endothelial cells | Increases leukocyte adhesions, inflammatory mediator, and prostaglandin production |
Tumor and stromal cells | Increases production of basement membrane-degrading proteinases involved in cancer invasion and metastasis Induces immune suppression, apoptosis resistance, and angiogenesis by means of induction of COX2–PGE2 pathway in tumor cells |
Hepatocytes | Increases acute phase C-reactive protein |
Leukocytes | Increases production of inflammatory cytokines, chemokines, and lipids |
COX2, cyclooxygenase 2; PGE2, prostaglandin E2.